ClinConnect ClinConnect Logo
Search / Trial NCT04078984

Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Sep 4, 2019

Trial Information

Current as of May 24, 2025

Completed

Keywords

Pressure Support Ventilation Mechanical Ventilation Weaning Time Driving Pressure Respiratory Weaning Acute Respiratory Distress Syndrome Ventilation Induced Lung Injury

ClinConnect Summary

Scientific justification :

As mechanical ventilation developed since the 1950s, researchers started to recognize characteristic lung disease associated with it, Nash et al giving an anatomopathological description of "Respiratory Lung" on post-mortem examination of lungs after mechanical ventilation in 1967 \[2\]. It progressively led to the concept of VILI and of the protective ventilation to minimize it, enhancing lower tidal volume and plateau pressure \[3\], controlled Driving Pressure \< 15cmH2O\[4\], neuromuscular blockade\[5\] and prone positioning\[6\]. However, these parameters ca...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient over 18 years old
  • Patients hospitalized in the ICU and who have suffered moderate to severe ARDS (Berlin criteria) equiped with nasogastric feeding tube allowing measures of Eadi
  • Exclusion Criteria:
  • COPD or measured or suspected auto-PEEP higher than 3 cmH2O at beginning of Pressure Support
  • Admission in the ICU more than 15 days before the initiation of weaning
  • Broncho-pleural leaks
  • ECMO
  • Pregnant woman.

About University Hospital, Bordeaux

The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.

Locations

Pessac, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials